Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.91M | 3.96M | 3.94M | 3.71M | 3.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.92M | 6.98M | 6.72M | 6.63M | 7.17M |
| Operating Income | -6.92M | -6.98M | -6.72M | -6.63M | -7.17M |
| Income Before Tax | -6.85M | -6.85M | -6.74M | -7.25M | -7.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.85 | -6.85 | -6.74 | -7.25 | -7.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.85M | -6.85M | -6.74M | -7.25M | -7.72M |
| EBIT | -6.92M | -6.98M | -6.72M | -6.63M | -7.17M |
| EBITDA | -6.84M | -6.91M | -6.65M | -6.56M | -7.09M |
| EPS Basic | -24.72 | -34.03 | -337.75 | -332.10 | -318.64 |
| Normalized Basic EPS | -15.43 | -21.27 | -38.12 | -34.59 | -26.18 |
| EPS Diluted | -24.72 | -34.03 | -337.75 | -332.10 | -318.64 |
| Normalized Diluted EPS | -15.43 | -21.27 | -38.12 | -34.59 | -26.18 |
| Average Basic Shares Outstanding | 1.80M | 1.01M | 664.80K | 318.00K | 179.50K |
| Average Diluted Shares Outstanding | 1.80M | 1.01M | 664.80K | 318.00K | 179.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |